CIK 0002056611 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Latigo Biotherapeutics, Inc.
Sign in to watch- Ticker
- LTGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832625838
- Phone
- 805-716-2927
- Business address
- 1300 RANCHO CONEJO BLVD., SUITE 305, THOUSAND OAKS, CA
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Conversion 10% owner acquired 7,325,962 shares (conversion)
- 4 Conversion 10% owner acquired 672,778 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Conversion 10% owner acquired 12,695,305 shares (conversion)
- 4 Open-market buy 10% owner bought 140,000 shares at $18.00 ($2,520,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 140,000 shares at $18.00 ($2,520,000)
- 4 Conversion Director acquired 12,695,305 shares (conversion)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Bylaws or fiscal year change · Other events
Page 1 of 3 · 44 filings